Mastectomy
Conditions
Interventions
A total of 930 women with clinical stage I-III breast cancer undergoing chemotherapy or radiotherapy after mastectomy treated at Aristides Maltez Hospital from January 2018 to December 2022 were inclu
V03.175.500
Sponsors
Hospital Aristides Maltez
Universidade Federal do Rio Grande do Sul
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Women aged 18 years or older; diagnosis of invasive breast carcinoma treated at Aristides Maltez Hospital; clinical staging I, II and III according to the American Joint Committee on Cancer 8th edition; patients undergoing mastectomy only; patients undergoing any type of mastectomy only and mastectomy associated with immediate implant-based breast reconstruction
Exclusion criteria
Exclusion criteria: Diagnosis of local and regional recurrence and distant metastases of breast cancer; diagnosis of de novo stage IV; inflammatory carcinoma; first adjuvant therapy not performed at Aristides Maltez Hospital; prophylactic mastectomy; incomplete neoadjuvant chemotherapy up to the time of mastectomy; tumor progression or clinical non-response to neoadjuvant chemotherapy; bilateral mastectomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the time (days and weeks) after surgery to start adjuvant therapy between groups of mastectomy with and without immediate breast reconstruction. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess whether immediate breast reconstruction interferes with the time (days and weeks) to start the first adjuvant therapy | — |
Countries
Brazil
Contacts
Public ContactLilian Paz
Hospital Aristides Maltez
Outcome results
None listed